Daré Bioscience (DARE) Revenue & Revenue Breakdown
Daré Bioscience Revenue Highlights
Latest Revenue (Y)
$2.81M
Latest Revenue (Q)
$41.69K
Main Segment (Y)
License And Collaboration Revenues
Daré Bioscience Revenue by Period
Daré Bioscience Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.81M | -71.92% |
2022-12-31 | $10.00M | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | -100.00% |
2016-12-31 | $766.00K | 100.00% |
2015-12-31 | - | -100.00% |
2014-12-31 | $80.00K | 1233.33% |
2013-12-31 | $6.00K | -99.04% |
2012-12-31 | $625.00K | - |
Daré Bioscience Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $41.69K | 85.81% |
2024-06-30 | $22.44K | 141.22% |
2024-03-31 | $9.30K | -99.49% |
2023-12-31 | $1.81M | 80.79% |
2023-09-30 | $1.00M | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $10.00B | 100.00% |
2022-09-30 | - | -100.00% |
2022-06-30 | $10.00M | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $-1.83M | 100.00% |
2017-09-30 | - | -100.00% |
2017-06-30 | $642.00K | -46.14% |
2017-03-31 | $1.19M | 55.61% |
2016-12-31 | $766.00K | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | -100.00% |
2014-06-30 | $33.00K | -29.79% |
2014-03-31 | $47.00K | 683.33% |
2013-12-31 | $6.00K | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | - |
Daré Bioscience Revenue Breakdown
Daré Bioscience Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 | Dec 20 |
---|---|---|
License And Collaboration Revenues | $10.00M | - |
Grant | - | $2.50M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Sep 23 | Sep 22 | Jun 22 |
---|---|---|---|---|
License And Collaboration Revenue | $12.80M | - | - | - |
License And Collaboration Revenues | - | $11.00M | $10.00M | $10.00M |
Latest
Daré Bioscience Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Sep 22 | Jun 22 |
---|---|---|
License And Collaboration Revenues | $10.00M | $10.00M |
Latest
Daré Bioscience Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ONTX | Traws Pharma | $226.00B | $56.00K |
ALEC | Alector | $97.06M | $15.08M |
EYPT | EyePoint Pharmaceuticals | $46.02M | $10.52M |
OCUP | Ocuphire Pharma | $19.05M | $1.11M |
PULM | Pulmatrix | $7.30M | $366.00K |
KZR | Kezar Life Sciences | $7.00M | - |
DARE | Daré Bioscience | $2.81M | $41.69K |
XBIO | Xenetic Biosciences | $2.54M | $614.24K |
CBIO | Gyre Therapeutics | $794.00K | - |
BDTX | Black Diamond Therapeutics | - | - |
BPTH | Bio-Path | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
CYTO | Altamira Therapeutics | - | $52.73K |
MBRX | Moleculin Biotech | - | - |
NXTC | NextCure | - | - |
GRPH | LENZ Therapeutics | - | - |
PASG | Passage Bio | - | - |
SNSE | Sensei Biotherapeutics | - | - |
MACK | Merrimack Pharmaceuticals | - | - |
SLS | SELLAS Life Sciences Group | - | - |
NUVB | Nuvation Bio | - | $727.00K |